Peginesatide in Patients Undergoing Hemodialysis | Now@NEJM | Organ Donation & Transplant Matters Resources | Scoop.it

In two new randomized, controlled studies involving patients undergoing long-term hemodialysis, dosing with peginesatide, a new synthetic peptide-based erythropoietin EPO analogue was effective.

 

This post from the @NEJM blog summarises the information from recently reported trials in an easy to read format.